Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 1.00 |
| ▸ | CNR1 | P21554 | 12/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 2/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 1.00 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 1.00 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 1.00 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2A6 | P11509 | 1/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | CYP2J2 | P51589 | 1/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 1.00 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabinol SCHEMBL29815206 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL121085 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL23460333 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL29350505 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL29814997 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL29814956 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL24713687 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL24714648 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL28565069 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL16061830 | 0.97 | CNR2 (0.93) | CNR2CNR1TRPA1TRPV1TRPV3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022251709-A1 | BIOACTIVE BIPHASIC COMPOSITIONS | Natural Extraction Systems, LLC (US) | 2022-12-01 | — | — | WO | claimed |
| US-20260000688-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING | GREENWAY HERBAL PRODUCTS LLC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20260000687-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING | GREENWAY HERBAL PRODUCTS LLC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12496307-B2 | Cannabinoid compositions and methods of using | GREENWAY HERBAL PRODUCTS, LLC (US) | 2025-12-16 | — | — | US | disclosed |
| EP-4658388-A1 | METHOD OF PURIFYING CANNABINOID COMPONENTS FROM PLANT EXTRACTS | Siegfried AG (CH) | 2025-12-10 | — | — | EP | disclosed |
| EP-4626412-A1 | FORMULATION COMPRISING APOCYNIN AND PAEONOL | AKL Research&Development Ltd (GB) | 2025-10-08 | — | — | EP | disclosed |
| US-12371412-B2 | Methods of preparing cannabinoids or derivatives thereof | FLORASCIENCE INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250214957-A1 | METHODS OF PREPARING CANNABINOIDS OR DERIVATIVES THEREOF | FLORASCIENCE INC. | 2025-07-03 | — | — | US | disclosed |
| US-12281091-B1 | Methods of preparing cannabinoids or derivatives thereof | FLORASCIENCE INC. (US) | 2025-04-22 | — | — | US | disclosed |
| EP-4514340-A1 | TREATMENT OF THE ADVERSE CARDIOVASCULAR EFFECTS OF CANNABINOIDS | Greenstone Biosciences, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| WO-2022213109-A2 | METHODS FOR ISOLATION AND PURIFICATION OF CANNABIDIOL (CBD) AND TERPENES FROM HEMP | RJ LEE GROUP, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| CN-115066234-A | Antibacterial treatment using cannabinoids and active agents | 博塔尼克斯药物有限公司 | 2022-09-16 | — | — | CN | disclosed |
| WO-2022187935-A1 | CATALYTIC CANNABINOL SYNTHESIS AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2022-09-15 | — | — | WO | disclosed |
| CN-115003290-A | Treatment of neisseria using cannabinoids | 博塔尼克斯药物有限公司 | 2022-09-02 | — | — | CN | disclosed |
| US-20220202765-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING | GREENWAY HERBAL PRODUCTS, LLC | 2022-06-30 | — | — | US | disclosed |
| EP-4019005-A1 | LIQUID FORMULATION COMPRISING PAEONOL AND APOCYNIN | AKL Research&Development Ltd (GB) | 2022-06-29 | — | — | EP | disclosed |
| US-20220162180-A1 | CANNABINOL-O-ACETATE SYNTHESIS, COMPOSITIONS, AND METHODS OF USE | Marquette Analytica (US) | 2022-05-26 | — | — | US | disclosed |
| WO-2022090876-A1 | GLUE FOR CIGARETTE PAPER, CIGARETTE PAPER AND PRODUCTION METHOD | Republic Technologies (North America) LLC (US) | 2022-05-05 | — | — | WO | disclosed |
| EP-3958856-A1 | COMPOSITIONS AND METHODS FOR USE OF CANNABINOIDS FOR NEUROPROTECTION | Inmed Pharmaceuticals Inc. (CA) | 2022-03-02 | — | — | EP | disclosed |
| CN-114007603-A | Compositions and methods for neuroprotection using cannabinoids | 因美制药公司 | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281091-B1 | Methods of preparing cannabinoids or derivatives thereof | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPA1 2446/4885 |
| US-20250214957-A1 | METHODS OF PREPARING CANNABINOIDS OR DERIVATIVES THEREOF | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPA1 2446/4885 |
| US-20260000688-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING | BECN1, CNR2, ATG13 | CNR2 2/4885CNR1 4/4885TRPA1 3490/4885 |
| US-20220162180-A1 | CANNABINOL-O-ACETATE SYNTHESIS, COMPOSITIONS, AND METHODS OF USE | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPA1 2817/4885 |
| US-20260000687-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING | CNR2, CNR1, ICOSLG | CNR2 1/4885CNR1 2/4885TRPA1 1670/4885 |
| US-12371412-B2 | Methods of preparing cannabinoids or derivatives thereof | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPA1 2446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.